These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 8828254)
21. Effects of beta-agonists on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Papiris S; Galavotti V; Sturani C Respiration; 1986; 49(2):101-8. PubMed ID: 3513269 [TBL] [Abstract][Full Text] [Related]
22. Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD. Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF Pulm Pharmacol Ther; 2014 Aug; 28(2):158-64. PubMed ID: 24076367 [TBL] [Abstract][Full Text] [Related]
23. Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise Endurance in Advanced Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial. Abdallah SJ; Smith BM; Ware MA; Moore M; Li PZ; Bourbeau J; Jensen D Ann Am Thorac Soc; 2018 Oct; 15(10):1146-1158. PubMed ID: 30049223 [TBL] [Abstract][Full Text] [Related]
24. Effects of inhaled anticholinergic drug on dyspnea and gas exchange during exercise in patients with chronic obstructive pulmonary disease. Teramoto S; Fukuchi Y; Orimo H Chest; 1993 Jun; 103(6):1774-82. PubMed ID: 8404100 [TBL] [Abstract][Full Text] [Related]
25. Two-month comparative study of tulobuterol aerosol versus fenoterol aerosol in patients with chronic obstructive lung disease. Werdermann K Lung; 1990; 168 Suppl():202-9. PubMed ID: 1974678 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Ofir D; Laveneziana P; Webb KA; Lam YM; O'Donnell DE Am J Respir Crit Care Med; 2008 Mar; 177(6):622-9. PubMed ID: 18006885 [TBL] [Abstract][Full Text] [Related]
27. Oxygen desaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromide. Spence DP; Hay JG; Carter J; Pearson MG; Calverley PM Thorax; 1993 Nov; 48(11):1145-50. PubMed ID: 8296259 [TBL] [Abstract][Full Text] [Related]
28. Effects of inhaled bronchodilators on pulmonary hemodynamics at rest and during exercise in patients with COPD. Saito S; Miyamoto K; Nishimura M; Aida A; Saito H; Tsujino I; Kawakami Y Chest; 1999 Feb; 115(2):376-82. PubMed ID: 10027435 [TBL] [Abstract][Full Text] [Related]
29. The effect of bronchodilators and oxygen alone and in combination on self-paced exercise performance in stable COPD. Cukier A; Ferreira CA; Stelmach R; Ribeiro M; Cortopassi F; Calverley PM Respir Med; 2007 Apr; 101(4):746-53. PubMed ID: 17000096 [TBL] [Abstract][Full Text] [Related]
30. A long-term study of symptoms, spirometry and survival amongst home nebulizer users. O'Driscoll BR; Bernstein A Respir Med; 1996 Oct; 90(9):561-6. PubMed ID: 8984531 [TBL] [Abstract][Full Text] [Related]
31. [The importance of the at risk COPD patients (Stage 0) and clinical differences]. Kömüs N; Tertemiz KC; Sevinç C Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073 [TBL] [Abstract][Full Text] [Related]
32. Long-term effects of inhaled anticholinergic drug on lung function, dyspnea, and exercise capacity in patients with chronic obstructive pulmonary disease. Teramoto S; Matsuse T; Sudo E; Ohga E; Katayama H; Suzuki M; Ouchi Y; Fukuchi Y Intern Med; 1996 Oct; 35(10):772-8. PubMed ID: 8933184 [TBL] [Abstract][Full Text] [Related]
33. An evaluation of nebulized levalbuterol in stable COPD. Datta D; Vitale A; Lahiri B; ZuWallack R Chest; 2003 Sep; 124(3):844-9. PubMed ID: 12970007 [TBL] [Abstract][Full Text] [Related]
34. Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD. Ijiri N; Kanazawa H; Yoshikawa T; Hirata K Int J Chron Obstruct Pulmon Dis; 2014; 9():1235-40. PubMed ID: 25395845 [TBL] [Abstract][Full Text] [Related]
35. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea. Diba C; King GG; Berend N; Salome CM Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of lung function and deposition of aerosolized bronchodilators carried by heliox associated with positive expiratory pressure in stable asthmatics: a randomized clinical trial. Alcoforado L; Brandão S; Rattes C; Brandão D; Lima V; Ferreira Lima G; Fink JB; Dornelas de Andrade A Respir Med; 2013 Aug; 107(8):1178-85. PubMed ID: 23664767 [TBL] [Abstract][Full Text] [Related]
37. [Effect duration and treatment effectiveness of salmeterol, fenoterol and salbutamol in severe forms of respiratory tract obstruction]. Vollmer M; Schmidt EW; Ulmer WT Pneumologie; 1995 Oct; 49(10):528-34. PubMed ID: 8584522 [TBL] [Abstract][Full Text] [Related]
38. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease. Ong KC; Kor AC; Chong WF; Earnest A; Wang YT Am J Respir Crit Care Med; 2004 May; 169(9):1028-33. PubMed ID: 14977622 [TBL] [Abstract][Full Text] [Related]
39. [Comparison of bronchodilator effects and site of action of fenoterol and ipratropium in chronic obstructive bronchitis]. Kheir A; Ying Y; Hannhart B; Duvivier C; Peslin R; Polu JM Rev Mal Respir; 1993; 10(1):9-15. PubMed ID: 8451502 [TBL] [Abstract][Full Text] [Related]
40. Reversibility tests in chronic obstructive airways disease: their predictive value with reference to benefit from domiciliary nebuliser therapy. Teale C; Morrison JF; Jones PC; Muers MF Respir Med; 1991 Jul; 85(4):281-4. PubMed ID: 1835110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]